Form 8-K - Current report:
SEC Accession No. 0001279569-25-000538
Filing Date
2025-05-27
Accepted
2025-05-27 09:50:41
Documents
14
Period of Report
2025-05-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 29062
2 NEWS RELEASE DATED MAY 23, 2025 ex991.htm EX-99.1 6267
3 GRAPHIC logo.jpg GRAPHIC 2326
  Complete submission text file 0001279569-25-000538.txt   204137

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20250523.xsd EX-101.SCH 3093
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20250523_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20250523_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3470
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 25984826
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)